🇺🇸 FDA
Patent

US 11666528

Drug implants containing enzalutamide and methods of use thereof

granted A61KA61K31/4166A61K47/34

Quick answer

US patent 11666528 (Drug implants containing enzalutamide and methods of use thereof) held by The Regents of the University of California expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/4166, A61K47/34, A61K9/0024, A61P